Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17

• Päätekijät: Yamane H (Tekijä), Ochi N (Tekijä), Nagasaki Y (Tekijä), Yamagishi T (Tekijä), Honda Y (Tekijä), Nakagawa N (Tekijä), Takeyama M (Tekijä), Nakanishi H (Tekijä), Takigawa N (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Dove Medical Press, 2018-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Hiromichi Yamane, Nobuaki Ochi, Yasunari Nagasaki, Tomoko Yamagishi, Yoshihiro Honda, Nozomu Nakagawa, Masami Takeyama, Hidekazu Nakanishi, Nagio Takigawa Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan Purpose: Cure-oriented treatment of malignant lymphoma (ML) is...